ACAD8

Across TCGA pan-cancer cohorts, ACAD8 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of ACAD8’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where ACAD8 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ACAD8 is over-expressed in tumor, although a few such as CCRCC and HNSC show the opposite, repressed pattern.

CCRCC, HNSC, and COAD are the cancer types where ACAD8 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ACAD8 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	All	−1.498	<.001	12	view →
HNSC	Male	II,III,IV	−1.180	<.001	11	view →
COAD	Female	II,III,IV	−0.317	<.001	10	view →
PDAC	Female	All	−0.858	<.001	9	view →
LUAD	Female	II,III,IV	+0.824	<.001	8	view →
LSCC	Male	II,III,IV	−0.488	<.001	8	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

ACAD8–CCRCC

Open the CCRCC breakdown →